What is SD PharmLabs?
Established in 2011, SD PharmLabs operates as a critical infrastructure provider for the cannabinoid, psychedelic, and nutraceutical markets. The company distinguishes itself through a high-touch, white-glove service model that prioritizes regulatory compliance, product safety, and operational efficiency. By offering rapid turnaround times and personalized pricing structures, PharmLabs enables its clients to maintain rigorous quality standards while optimizing their own cost structures. The firm's commitment to analytical accuracy and client-centric support has made it a trusted partner for businesses navigating the complexities of regulated and non-regulated product testing.
How much funding has SD PharmLabs raised?
SD PharmLabs has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
Key Investors in SD PharmLabs
PPP
Public-Private Partnership
What's next for SD PharmLabs?
With the infusion of this recent capital, SD PharmLabs is poised to accelerate its strategic growth initiatives. The company is expected to focus on expanding its laboratory capacity and enhancing its proprietary testing methodologies to meet the increasing demand for safety verification in the rapidly evolving nutraceutical and psychedelic sectors. As the regulatory landscape for these industries continues to mature, PharmLabs is strategically positioned to capture additional market share by providing the essential compliance data that manufacturers require to scale safely. Future efforts will likely prioritize technological integration to further reduce turnaround times and maintain the competitive edge that has defined its operational success to date.
See full SD PharmLabs company page
